Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,755 public trials 5,052 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

NCT06648889

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University Hospital Augsburg, II. Medizinischen Klinik, Hämatologie, internistische Onkologie und Hämostaseologie Augsburg, Germany
  • Charité Berlin, Campus Benjamin Franklin, Department of Hematology, Oncology and Tumorimmunologyt Hämatologie Berlin, Germany
  • Gesundheit Nord Klinikverbund Bremen gGmbH, Klinikum Bremen-Mitte, Med. Klinik I Bremen, Germany
  • Klinikum Carl Gustav Carus Dresden, Medizinische Klinik und Poliklinik I Dresden, Germany
View all 15 locations
View Trial Details
Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT07518186

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
View all 151 locations
View Trial Details
Recruiting

A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT05160584

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • LKH Leoben Leoben, Austria
  • Krankenhaus der barmherzigen Schwestern Vienna, Austria
  • UZ Antwerpen Edegem, Belgium
  • Ziekenhuis Oost-Limburg Genk, Belgium
View all 90 locations
View Trial Details
Recruiting

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT05327114

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • IMMUNOe Health and Research Centers Centennial, Colorado, United States
  • Healthcare Innovations Institute Inc Coral Springs, Florida, United States
  • Neurology Associates PA Maitland, Florida, United States
  • ALS Center at the University of Miami Miami, Florida, United States
View all 120 locations
View Trial Details
Recruiting

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

NCT07438496

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
Locations
  • David S Hallegua MD A Professional Corporation Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Southland Arthritis and Osteoporosis Medical Center Inc dba Southland Arthritis Hemet, California, United States
  • Advanced Medical Research La Palma, California, United States
View all 249 locations
View Trial Details
Recruiting

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

NCT07404865

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Arizona Arthritis & Rheumatology Associates P.C. Chandler, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates P.C. Flagstaff, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates, PLLC Glendale, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates P.C. Phoenix, Arizona, United States
View all 43 locations
View Trial Details
Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

NCT05947851

Conditions
CLL, Chronic Disease, Disease Attributes, +18 more
Locations
  • Highlands Oncology Group ( Site 5405) Springdale, Arkansas, United States
  • MemorialCare Health System - Long Beach Medical Center ( Site 5421) Long Beach, California, United States
  • Memorial Hospital West ( Site 5410) Pembroke Pines, Florida, United States
  • Oregon Health and Science University ( Site 5425) Portland, Oregon, United States
View all 65 locations
View Trial Details
Recruiting

A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis

NCT06978725

Conditions
Cutaneous Sarcoidosis, Hemic and Lymphatic Diseases, Hypersensitivity, +5 more
Locations
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site Durham, North Carolina, United States
  • Clinical Trial Site Philadelphia, Pennsylvania, United States
  • Clinical Trial Site Madison, Wisconsin, United States
View Trial Details

Related conditions